Detalles de la búsqueda
1.
Modified response evaluation criteria in solid tumors: A better response evaluation criteria for patients with non-squamous non-small cell lung cancer after bevacizumab treatment.
Asia Pac J Clin Oncol
; 20(1): 101-108, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898825
2.
Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial.
J Cancer Res Clin Oncol
; 149(14): 12713-12721, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452849
3.
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2.
Nat Microbiol
; 7(7): 1063-1074, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773398
4.
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Genome Med
; 13(1): 164, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649620
5.
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Cell Mol Immunol
; 17(6): 621-630, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415260
Resultados
1 -
5
de 5
1
Próxima >
>>